Report no. 81/2014

Amendment to a significant contract in the subsidiary company “Mikulicz” sp. z o.o. in Świebodzice

Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A., in connection with receiving as of 22 August 2014 an annex to the contract concluded with the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) signed by the subsidiary company “Mikulicz” sp. z o.o. regarding healthcare services in the scope of  palliative and hospice care  for the period  1 January to 31 December 2014.

Healthcare services referred to hereinabove are provided by the subsidiary company “Mikulicz” Sp. z o.o. in Świebodzice owned by EMC Instytut Medyczny S.A.
The Issuer informed about the contracts concluded by Mikulicz sp. z o.o. with the Fund Branch concerning rendering  healthcare services in 2014 in its currents report nos. 16/2014 of 27.01.2014, 23/2014 of 04.02.2014 and 64/2014 of 04.07.2014.
W wyniku podpisania ww. aneksu wartość umowy o największej wartości nie uległa zmianie.
Łączne maksymalne zobowiązanie Oddziału Funduszu wobec Spółki zależnej za okres od 1 stycznia do 31 grudnia 2014 roku wynosi obecnie 14 627 082,40 zł (wzrost o 6 000 zł).

As a result of signing the said annex, the value of the contract with highest value has  not changed. The total maximum Fund Branch liability towards the subsidiary company currently amounts to PLN  14,627,082.40 (an increase by PLN 6,000.00) in the period 1 January to 31 December 2014.

A criterion for a contract to be considered significant:
The value of contracts exceeds 10% of the Issuer’s equity capital.